Stock Price Quote

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE1339.65-5.2 (-0.39 %)
PREV CLOSE ( ) 1344.85
OPEN PRICE ( ) 1358.00
BID PRICE (QTY) 1338.05 (1)
OFFER PRICE (QTY) 1340.00 (10)
VOLUME 440
TODAY'S LOW / HIGH ( )1325.10 1358.00
52 WK LOW / HIGH ( )1131.05 1745
NSE1336.45-8.2 (-0.61 %)
PREV CLOSE( ) 1344.65
OPEN PRICE ( ) 1351.00
BID PRICE (QTY) 1336.55 (10)
OFFER PRICE (QTY) 1338.85 (10)
VOLUME 8848
TODAY'S LOW / HIGH( ) 1325.00 1353.00
52 WK LOW / HIGH ( )1130 1748
BSE NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-11 1924
Management Info
R S Karnad - Chairman A Vaidheesh - Managing Director
Registered Office

Address Dr Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com

Website www.gsk-india.com

Registrars Details
KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
 Listing : BSE, NSE, MCX

NEWS

04Feb Glaxosmithkline Pharmaceuticals report
Glaxosmithkline Pharmaceuticals has reported results for third quarter e..
23Jan GlaxoSmithKline Pharmaceuticals inform
Pursuant to Regulation 39 and other application regulations of SEBI (Lis..
17Jan Glaxosmithkline Pharmaceuticals inform
Glaxosmithkline Pharmaceuticals has informed that pursuant to Regulation..
23Oct Glaxosmithkline Pharmaceuticals report
Glaxosmithkline Pharmaceuticals has reported results for second quarter..
26Sep GlaxoSmithkline Pharmaceuticals recall
GlaxoSmithkline Pharmaceuticals has recalled ranitidine hydrochloride ta..
MORE

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit-6441.44253.6
Gross Profit -6173.1 6637.1
Operating Profit 14097079.6
Net Sales 7786.831285.3
MORE

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  7415.20 (1.26%)
M.Cap ( in Cr)17034.37
Solara Active Pharma (BSE)
peergroup  719.50 (5.77%)
M.Cap ( in Cr)1844.06
Jenburkt Pharma (BSE)
peergroup  405.50 (9.27%)
M.Cap ( in Cr)188.16
Astrazeneca Pharma I (BSE)
peergroup  2829.00 (0.96%)
M.Cap ( in Cr)7053.50
Shilpa Medicare (BSE)
peergroup  490.70 (5.00%)
M.Cap ( in Cr)4000.52
MORE

Shareholding Pattern

PROMOTERS 75%
FI/BANKS/INSURANCE 7.05%
MUTUAL FUNDS/UTI 3.97%
NON-INSTITUTION 13.47%
FII 0%
GOVERNMENT 0%
MORE

Mf Holdings

MORE

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd. was incorporated in the year 1924. Its today's share price is 1344.85. Its current market capitalisation stands at Rs 22584.37 Cr. In the latest quarter, company has reported Gross Sales of Rs. 31281.19 Cr and Total Income of Rs.32304.36 Cr. The company's management includes S Williams, P Thakur, D Sundaram, A N Roy, R Krishnaswamy, N Kaviratne ( C B E ), PV Bhide, A Bansal, A Vaidheesh, R S Karnad.

It is listed on the BSE with a BSE Code of 500660 , NSE with an NSE Symbol of GLAXO and ISIN of INE159A01016. It's Registered office is at Dr Annie Besant Road,Worli,Mumbai-400030, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Lovelock & Lewes, Price Waterhouse & Co, Price Waterhouse & Co Bangalore LLP

download beyond app
About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang
Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Margin Funding Algo Trading
Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays
Derivatives Updates Market Report Overview
IPO IPO Issues Performance News & Analysis
Commodities Market Movers News & Commentary MCX / NCDEX Holidays
Mutual Funds About Nirmal Bang Wealth Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy
Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research
Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap
Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI ScoresRMS Policy
Connect with Us
ATTENTION INVESTORS Depository IPO KYC
Inactive account treatmentNBSPL Policy of AMLNBEPL Policy of AMLNBCPL Policy of AMLNBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar UpdationNirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019
Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300
For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain.     |    

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X
AppleApp Store GooglePlay Store
AppleApp StoreGooglePlay Store
Support
Videos